Top

Published in:

01-08-2012 | Current Opinion

Comparative Effectiveness and Child Health

Author: Dr Lisa A. Prosser, PhD

Published in: PharmacoEconomics | Issue 8/2012

Abstract

Comparative effectiveness research is expected to play an important role in future clinical and policy decision making in the US; however, the application of comparative effectiveness methodologies to child health requires special attention to aspects of health and healthcare that are specific to children. These special considerations include the role of parent/caregiver as joint decision maker and co-participant in many types of interventions, how the effectiveness of an intervention varies by age and developmental stage, and the difficulties in translating short-term data from childhood into projected effectiveness over the lifespan. Each aspect of comparative effectiveness, such as conducting new studies, synthesizing existing evidence, emphasizing real-world settings, considering multiple decision makers, and measuring patient-relevant outcomes, will require expanded definitions when considered in the context of child health.

This paper discusses how comparative effectiveness methods and concepts will differ when applied to child health and suggests a potential role for decision analysis as a method to synthesize data and project long-term outcomes. The initiation of comparative effectiveness studies for children represents an exciting opportunity to provide evidence that can guide clinical and policy decisions for child health.

Sox HC. Comparative effectiveness research: a progress report. Ann Intern Med. 2010 Oct 5; 153(7): 469–72PubMedCrossRef

Sullivan P, Goldmann D. The promise of comparative effectiveness research. JAMA 2011 Jan 26; 305(4): 400–1PubMedCrossRef

Agency for Healthcare Research and Quality. What is comparative effectiveness research [online]. Available from URL: http://www.effectivehealthcare.ahrq.gov/index.cfm/what-is-comparative-effectiveness-research1/ [Accessed 2011 Sep 8]

Federal Coordinating Council for Comparative Effectiveness Research. Report to the President and the Congress. Washington, DC: US Department of Health and Human Services, 2009 Jun 30 [online]. Available from URL: http://www.hhs.gov/recovery/programs/cer/cerannualrpt.pdf [Accessed 2012 May 18]

Institute of Medicine of the National Academies. Initial national priorities for comparative effectiveness research. Washington, DC: National Academies Press, 2009 [online]. Available from URL: http://www.iom.edu/Reports/2009/ComparativeEffectivenessResearchPriorities.aspx [Accessed 2011 Sep 8]

Mayer D. Essential evidence-based medicine. Cambridge: Cambridge University Press, 2004

Hennekens C, Buring J. Epidemiology in medicine: Boston (MA): Little, Brown and Company, 1987

Guiding comparative effectiveness research — a US perspective: an interview between Howard Birnbaum (of Analysis Group, Inc., and guest co-editor of this special issue) and Jean R. Slutsky (Director, Center for Outcomes and Evidence, Agency for Healthcare Research and Quality). Pharmacoeconomics 2010; 28 (10): 839–42

Wilensky GR. Developing a center for comparative effectiveness information. Health Affair 2006 Nov–Dec; 25(6): w572–85CrossRef

10.

Neumann PJ. What next for QALYs? JAMA 2011 May 4; 305(17): 1806–7PubMedCrossRef

11.

Weinstein MC, Skinner JA. Comparative effectiveness and health care spending: implications for reform. N Engl J Med 2010 Feb 4; 362(5): 460–5PubMedCrossRef

12.

Garber AM, Sox HC. The role of costs in comparative effectiveness research. Health Affair 2010 Oct; 29(10): 1805–11CrossRef

13.

Sobo EJ, Kurtin PS, editors. Child health services research. San Francisco (CA): Jossey-Bass, 2003

14.

Forrest CB, Simpson L, Clancy C. Child health services research: challenges and opportunities. JAMA 1997 Jun 11; 277(22): 1787–93PubMedCrossRef

15.

Drotar D, editor. Measuring health-related quality of life in adolescents: implications for research and practice. Mahwah (NJ): Lawrence Erlbaum Associates, 1998

16.

Ungar WJ, editor. Economic evaluation in child health. Oxford: Oxford University Press, 2010

17.

Mullins CD, Whicher D, Reese ES, et al. Generating evidence for comparative effectiveness research using more pragmatic randomized controlled trials. Pharmacoeconomics 2010; 28(10): 969–76PubMedCrossRef

18.

Schmier J, King J, Nichol K, et al. Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trial. Health Affair 2008; 27(2): w96–104CrossRef

19.

King Jr JC, Stoddard JJ, Gaglani MJ, et al. Effectiveness of school-based influenza vaccination. N Engl J Med 2006 Dec 14; 355(24): 2523–32PubMedCrossRef

20.

Culyer AJ. Perspective and desire in comparative effectiveness research: the relative unimportance of mere preferences, the central importance of context. Pharmacoeconomics 2010; 28(10): 889–97PubMedCrossRef

21.

Prosser LA, Hammitt JK, Keren R. Measuring health preferences for use in cost-utility and cost-benefit analyses of interventions in children: theoretical and methodological considerations. Pharmacoeconomics 2007; 25(9): 713–26PubMedCrossRef

22.

Petrou S. Should health gains by children be given the same value as health gains by adults in an economic evaluation framework? In: Ungar WJ, editor. Economic evaluation in child health. Oxford: Oxford University Press, 2010: 271–87

23.

Ungar WJ, Gerber A. The uniqueness of child health and challenges to measuring costs and consequences. In: Ungar WJ, editor. Economic evaluation in child health. Oxford: Oxford University Press, 2010: 3–32

24.

Haddix AC, Teutsch SM, Corso PS. Prevention effectiveness: a guide to decision analysis and economic evaluation. 2nd rev. ed. Oxford: Oxford University Press, 2003

25.

Goldie SJ, Corso PS. Decision analysis. In: Haddix AC, Teutsch SM, Corso PS, editors. Prevention effectiveness: a guide to decision analysis and economic evaluation. 2nd rev. ed. New York: Oxford University Press, 2003: 103–26

26.

Weinstein MC. Clinical decision analysis. Philadelphia (PA): Saunders, 1980

27.

Hunink MGM, Glasziou PP, Siegel JE, et al. Decision making in health and medicine: integrating evidence and values. New York: Cambridge University Press, 2001

28.

Caro JJ, Ishak KJ. No head-to-head trial? Simulate the missing arms. Pharmacoeconomics 2010; 28(10): 957–67PubMedCrossRef

29.

Mandelblatt JS, Cronin KA, Bailey S, et al. Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms. Ann Intern Med 2009; 151(10): 738–47PubMedCrossRef

30.

Kong CY, Lee JM, McMahon PM, et al. Using radiation risk models in cancer screening simulations: important assumptions and effects on outcome projections. Radiology 2012; 262(3): 977–84PubMedCrossRef

31.

Prosser LA, Kuntz KM, Bar-Or A, et al. Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosis. Value Health 2004; 7(5): 554–68PubMedCrossRef

32.

Prosser LA, Stinnett AA, Goldman PA, et al. Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med 2000; 132(10): 768–79CrossRef

33.

Prosser LA, Kong CY, Rusinak D, et al. Projected costs, risks, and benefits of expanded newborn screening for MCADD. Pediatrics 2010; 125(2): e286–94PubMedCrossRef

34.

Wang YC, Cheung AM, Bibbins-Domingo K, et al. Effectiveness and cost-effectiveness of blood pressure screening in adolescents in the United States. J Pediatr 2011 Feb; 158(2): 257–64, e 1–7PubMedCrossRef

35.

Vijgen SMC, Hoogendoorn M, Baan CA, et al. Cost effectiveness of preventive interventions in type 2 diabetes melliltus. Pharmacoeconomics 2006; 24(5): 426–41CrossRef

36.

Wang YC. Estimating the energy gap among US children: a counterfactual approach. Pediatrics 2006; 118: 1721–33CrossRef

37.

Prosser LA, Grosse SD, Kemper AR, et al. Decision analysis, economic evaluation, and newborn screening: challenges and opportunities. Genet Med 2012. Epub 2012 Apr 5

38.

Owens DK, Qaseem A, Chou R, et al. High-value, cost-conscious health care: concepts for clinicians to evaluatethe benefits, harms, and costs of medical interventions. Ann Intern Med 2011 Feb 1; 154(3): 174–80PubMedCrossRef

39.

Qaseem A, Snow V, Owens DK, et al. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med 2010 Aug 3; 153(3): 194–9PubMedCrossRef

40.

Simpson LA, Peterson L, Lannon CM, et al. Special challenges in comparative effectiveness research on children’s and adolescents’ health. Health Affair 2010 Oct; 29(10): 1849–56CrossRef

41.

Landrigan PJ, Trasande L, Thorpe LE, et al. The National Children’s Study: a 21-year prospective study of 100,000 American children. Pediatrics 2006 Nov; 118(5): 2173–86PubMedCrossRef

Title: Comparative Effectiveness and Child Health
Author: Dr Lisa A. Prosser, PhD
Publication date: 01-08-2012
Publisher: Springer International Publishing
Published in: PharmacoEconomics / Issue 8/2012
Print ISSN: 1170-7690
Electronic ISSN: 1179-2027
DOI: https://doi.org/10.2165/11633830-000000000-00000

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Comparative Effectiveness and Child Health

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2012

Valuation of the Child Health Utility 9D Index

Valuing Children’s Health

Cost Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Stimulant Compared with Stimulant Monotherapy for the Treatment of Attention-Deficit Hyperactivity Disorder in Children and Adolescents

Economic Evaluations of Childhood Influenza Vaccination

The Impact of Rotavirus Vaccination on Discounted Net Tax Revenue in Egypt

A Parent-Child Dyad Approach to the Assessment of Health Status and Health-Related Quality of Life in Children with Asthma